| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc. (APLS) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. APLS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.18M | $48.30M | - | |
| CEO | 482.0K | $19.78M | - | |
| Dir | 385.0K | $15.80M | - | |
| Dir | 161.6K | $6.63M | - | |
| CFO | 152.0K | $6.24M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2022 | Townsend Adam J.74 | Chief Commercial Officer | Sale+OE | 5,000 | $50.38 | $251,900.00 | -10.4% | +30.2% | +31.3% | |
| Dec 1, 2022 | Dunlop A. Sinclair62 | Director | Sell | 500 | $49.93 | $24,965.00 | -0.4% | +28.5% | +23.7% | |
| Dec 1, 2022 | Grossi Federico53 | Chief Medical Officer | Sell | 2,500 | $49.93 | $124,825.00 | -2.5% | +28.5% | +23.7% | |
| Nov 15, 2022 | MacHiels Alec57 | Director | Sale+OE | 1,250 | $48.01 | $60,012.50 | -0.5% | +11.4% | +3.8% | |
| Nov 8, 2022 | Deschatelets Pascal69 | Chief Scientific Officer | Sale+OE | 12,000 | $46.47 | $557,640.00 | -1.2% | +17.2% | -0.3% | |
| Nov 3, 2022 | Townsend Adam J.74 | Chief Commercial Officer | Sale+OE | 5,000 | $58.54 | $292,700.00 | -10.4% | -8.4% | -22.0% | |
| Nov 1, 2022 | Dunlop A. Sinclair62 | Director | Sell | 500 | $60.83 | $30,415.00 | -0.4% | -13.1% | -17.7% | |
| Nov 1, 2022 | Grossi Federico53 | Chief Medical Officer | Sell | 2,500 | $60.83 | $152,075.00 | -2.4% | -13.1% | -17.7% | |
| Oct 14, 2022 | MacHiels Alec57 | Director | Sale+OE | 1,250 | $59.31 | $74,137.50 | -0.5% | -7.5% | -14.9% | |
| Oct 10, 2022 | Deschatelets Pascal69 | Chief Scientific Officer | Sale+OE | 12,000 | $57.50 | $690,000.00 | -1.2% | -17.7% | -23.3% |